Related Experiment Video
Updated: Jul 1, 2026

10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
Terbium-161 might be superior to lutetium-177 for oligometastases - Authors' reply
Bastiaan M Privé1, Walter Noordzij2, Steffie Peters3
1Department of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, Netherlands; Department of Radiation Oncology, Erasmus MC, Rotterdam, Netherlands; Department of Medical Imaging, Radboudumc, Radboud Institute for Health Sciences, 6500 HB Nijmegen, Netherlands.
The Lancet. Oncology
|June 29, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
Nuclear Transmutation
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed protons being...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

